Ind. Code ch. 25-22.5-13

Ind. Code ch. 25-22.5-13
in effect

Ind. Code § 25-22.5-13-1 Rules concerning review of records by attorney general

Sec. 1. (a) The board shall adopt rules in the manner provided under IC 4-22-2 to establish standards and procedures to do the following: (1) Receive and review petitions from the attorney general seeking board authorization to examine a physician's records and controlled substances inventory and materials to investigate the physician's controlled substances prescribing practices. (2) Authorize, where appropriate, the attorney general to examine records, materials, and inventory relating to the physician's controlled substance prescribing practices. (3) Provide safeguards and protections for physicians against unreasonable and oppressive examination authorizations and actions taken to carry out the authorizations, including limitations on interference with regular practice operations and other appropriate due process provisions. (b) The rules adopted under this section do not abrogate or eliminate the attorney general's investigative authority under IC 4-6-3-3, IC 4-6-10-3, IC 25-1-7-4, or any other applicable statute or rule. As added by P.L.185-2013, SEC.3. Amended by P.L.93-2024, SEC.183.

Ind. Code § 25-22.5-13-2 Rules establishing standards and protocols

Sec. 2. Consistent with standard medical practices in pain management treatment, the medical licensing board shall adopt rules under IC 4-22-2 to establish standards and protocols for the prescribing of controlled substances, including the use of abuse deterrent formulations. As added by P.L.185-2013, SEC.3. Amended by P.L.54-2015, SEC.1.

Ind. Code § 25-22.5-13-3 Rules by boards concerning opioid controlled substances

Sec. 3. (a) Before March 1, 2016, the: (1) board, concerning physician assistants; (2) board of podiatric medicine, concerning podiatrists; (3) state board of dentistry, concerning dentists; and (4) Indiana state board of nursing, concerning advanced practice registered nurses; shall adopt rules necessary to complement the rules for prescribing opioid controlled substances for pain management treatment adopted by the board under sections 1 and 2 of this chapter. (b) Before December 31, 2015, each board specified in subsection (a) shall provide a report in an electronic format under IC 5-14-6 to the legislative council providing a status report on efforts to adopt the rules required by subsection (a). The status report must include: (1) a copy of the board's rulemaking docket required by IC 4-22-2-22.5; and (2) a reasonable estimate of the timetable for action required under IC 4-22-2-22.5(d)(8). As added by P.L.185-2013, SEC.3. Amended by P.L.54-2015, SEC.2; P.L.129-2018, SEC.27.

Ind. Code § 25-22.5-13-5 Rules to address emergency matters of health and safety

Sec. 5. For purposes of Executive Order 13-03, the predominate purpose and effect of rules adopted under this chapter is to address emergency matters of health and safety. As added by P.L.185-2013, SEC.3.

Ind. Code § 25-22.5-13-6 Prescribing of methadone for pain; inclusion on prescription or order

Sec. 6. If a prescriber is prescribing methadone for a patient for the treatment of pain or pain management, the prescriber shall include on the prescription or order that the prescription is for the treatment of pain. As added by P.L.209-2015, SEC.18.

Ind. Code § 25-22.5-13-7 INSPECT program report in patient's medical file

Sec. 7. A physician may include a report from the INSPECT program in a patient's medical file. Any disclosure or release of a patient's medical file must be in compliance with IC 25-26-24-19. As added by P.L.82-2016, SEC.4. Amended by P.L.51-2019, SEC.6.

Ind. Code § 25-22.5-13-8 Rules concerning conditions exempted from opioid prescription limitations

Sec. 8. The medical licensing board of Indiana shall, in consultation with the Indiana department of health, the office of the secretary of family and social services, and representatives of prescriber stakeholders, adopt rules under IC 4-22-2 setting forth the conditions the board considers necessary under IC 25-1-9.7-2(b)(1)(D) to be exempted from the prescribing limitations set forth in IC 25-1-9.7-2(a). As added by P.L.182-2017, SEC.2. Amended by P.L.56-2023, SEC.235; P.L.93-2024, SEC.185.
Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://iga.in.gov/laws/2026/ic/titles/25Fetched: 10/17/2026

Starting a business in Indiana? Indiana LLC guide: costs and requirements